Adagene Statistics
NASDAQ: ADAGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.76-0.25 (-12.44%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Adagene by the numbers
Adagene has a market capitalization of $118.2 million based on 67.14M shares outstanding. With trailing EPS of $-0.37, Adagene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 31.0% below its 50-day average and 48.1% below its 200-day average.
Average daily trading volume is 348.81K shares, or about $613,914 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADAG valuation vs. peer median
| Metric | ADAG | Peer median | Difference |
|---|---|---|---|
| Market cap | $118.17M | $111.11M | +6% |
| Avg. volume | 348.81K | 212.56K | +64% |
Peer median across 8 companies: MSLE, OKUR, MGNX, IMUX, MENS, SPRB, BGM, SION.
Valuation
- Market cap
- $118.17M
- Price / sales (latest FY)
- 15.41
- EPS (TTM)
- $-0.37
- Shares outstanding
- 67.14M
Price and trading
- Previous close
- 2.01
- Open
- 2.00
- Day range
- 1.35 – 2.05
- 52-week range
- 1.27 – 4.85
- 52-week change
- -2.22%
- Beta
- —
- Volume
- 1.37M
- Average volume
- 348.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jul 23, 2025
Additional statistics
- Market Cap
- 118.17M
- Forward Pe
- -3.14
- Eps
- -0.37
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.85
- Week52 Low
- 1.27
- Avg Volume
- 348.81K
- Shares Outstanding
- 67.14M
- Ma50
- 2.55
- Ma200
- 3.39
- Earnings Date
- Jul 23, 2025
- Pct From52w High
- -63.71%
- Pct From52w Low
- 38.91%